A potassium-chloride co-transporter with altered genome architecture functions as a suppressor in glioma

Hongwei Liu1,2, Zhouyang Pan1,2, Xuelei Lin1,2

  • 1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.

Insights

This study identifies the potassium-chloride transporter SLC12A5 as a potential suppressor of glioma progression. Lower SLC12A5 levels correlate with poor prognosis, while its overexpression inhibits tumor cell growth and migration.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genomics

Background:

  • Gliomas are aggressive brain tumors with poor outcomes despite standard treatments.
  • Tumor heterogeneity and complex regulatory mechanisms limit current therapeutic efficacy.
  • Identifying novel molecular targets is crucial for improving glioma treatment.

Purpose of the Study:

  • To investigate the role of the potassium-chloride transporter SLC12A5 in glioma.
  • To characterize SLC12A5's association with glioma pathology, prognosis, and molecular features.
  • To evaluate SLC12A5's functional impact on glioma cell behavior and immune response.

Main Methods:

  • Analysis of Hi-C data to identify SLC12A5 in disrupted topologically associating domains.
  • Validation across multiple independent glioma cohorts.
  • Functional studies using SLC12A5-overexpressing cell lines.
  • Correlation analysis with genomic alterations, transcriptional landscape, and immune signatures.

Main Results:

  • SLC12A5 was found to be downregulated in glioma tissues.
  • Downregulation of SLC12A5 significantly correlated with pathological features, poor prognosis, and specific genomic alterations.
  • Overexpression of SLC12A5 suppressed glioma cell proliferation and migration in vitro.
  • SLC12A5 expression was positively associated with GABAergic activity and negatively with pro-tumorigenic immune signatures.

Conclusions:

  • SLC12A5 is a potential tumor suppressor in glioma.
  • SLC12A5's downregulation is linked to aggressive disease characteristics and poor immunotherapy response.
  • SLC12A5 represents a promising therapeutic target for glioma treatment.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.6K